chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My breast right adjacent to the areola itched and then it turned into a rash with blisters which approximately was on the 02/16/2021. Worst itch I've ever had in my life. My OBGYN put me on Valacyclovir-Valtrex. Also put me on a cream containing steroids. It was awful. This was shingles. With Dr. 02/18/2021, my blood pressure was not remarkable at that visit. When I went to the breast specialist APRN on 02/24/2021, she looked at the breast and also took my blood pressure and it went up 40 points. As far as I remember it was 180/100 around there. Scary blood pressure. She didn't put me on blood pressure medicine, but she gave me a different cream for the rash. OTC CeraVe antihistamine cream. As of 04/01/2021, I saw my cardiologist and wanted to see him about the BP. I was tried on two different medications but they both caused side effects, so I stopped taking them. Metoprolol and Bisoprolol. Unclear of exact dates. Just watched it over the course of time. Discomfort in the back behind my knee but not in the knee itself. Mentioned that to my doctor and it felt weird. Dermatologist on 04/26/2021 pointed out to me that I have edema in my leg. I just had some discomfort, so it went nowhere and it was vague. My dermatologist noted for me that I had edema and we went on from there. I saw my GP on 07/15/2021 and I'm pretty sure it was for the discomfort in the leg and she wondered for DVT and sent me for an ultrasound of my leg looking for DVT around that period of time. My GP oversaw a lot of this. This went on for months and it was very vague for months. It wasn't interfering with anything at this time. I had the one test for the DVT and I did not have that. The test moved along and on 08/12/2021, I think I had a more thorough and intensive ultrasound of my leg and they found a superficial vein thrombosis. I have two doctors who had to do with that. Vein doctor and doctor who did the test. That one just took months because it didn't feel right and they were trying to figure it out. The vein doctor wanted me to wear compression socks and I cannot physically get it on. I essentially did nothing about the clot. I'm going back for a recheck sometime soon. Recovered from Shingles. Improved blood pressure even without medication. Leg has not improved, still uncomfortable but getting used to it, still getting the edema.
Hives (blotchy marks) anterior and inner bilateral thighs. Complaining of itch.
J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/6/2023 ACUTE HYPOXEMIC RESPIRATORY FAILURE J96.10 CHRONIC RESPIRATORY FAILURE 4/27/2023 ACUTE HYPOXEMIC RESPIRATORY FAILURE
I immediately started experiencing a severe headache that lasted for 2 months after Dose 1. My doctor advised me at first not to take the vaccine. I did anyway so I could see my new grandchild and the headache continued after Dose 2. As of present I'm still suffering from fatigue.
Received vaccine 3/27/15 w/well child visit and mom noticed rash on his neck and fever starting 4/6/15-fever 102 at the highest. Responds to TYLENOL, eating and drinking well.
Information has been reported in a CDC slide titled as "Safety of PNEUMOVAX 23 in the Vaccine Adverse Reporting System (VAERS)". This spontaneous prospective pregnancy report as received from a registered nurse (RN) in Centers for Disease Control and Prevention (CDC) concerning a female patient of unknown age, 1 of the five patients who experienced local reactions. On an unknown date, the patient became pregnant. The last menstrual period (LMP) and estimated date of delivery (EDD) was not known. On an unknown date the patient was administered with a dose of PNEUMOVAX 23 (lot#, dose and route were unspecified) during pregnancy. On an unknown date the patient experienced local reactions. The outcome of local reactions was unknown. The pregnancy outcome was unknown. This is one of the 18 reports (PNEUMOVAX 23 administered during pregnancy) that received from the same source. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Pharmacist mentioned a shipment of live ZOSTAVAX and live (Merck) VARIVAX were received with a 4 days shipping time period were given to patients (unknown date). Pharmacist stated the shipment was received and the ice packs were still frozen and the live ZOSTAVAX and live (Merck) VARIVAX were stored in the freezer. There were 9 patients who received live ZOSTAVAX and on 25-JAN-2013, one patient a dose of live (Merck) VARIVAX lot # H016715, Expire date: 07-SEP-2014 (route and dose not reported). No concomitant medications were reported. The patient was not experiencing any known symptoms. Patient's outcome was unknown. This is one of several reports from the same source. Additional information has been requested.
lower back pains/lower back started hurting; hips started hurting; the pain has moved around and changed; This is a spontaneous report from a contactable consumer (patient). A female patient (Age: 79; Unit: Unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID VACCINE, solution for injection, Batch/Lot Number: was not reported) via an unspecified route of administration on 29Jan2021 (Friday) as single dose for covid-19 immunization. The patient's medical history included back pain. The patient's concomitant medications were not reported. On 31Jan2021 (Sunday), the patient experienced lower back pains/lower back started hurting, hone of her hips started hurting and the pain has moved around and changed. She is still having trouble. She can barely lean over and get up. She wanted to know if that is a side effect from vaccine or what. She is going back in two weeks for her second shot. She wants to know if it is safe to take the second shot. She has been down in her back before so she doesn't know if it is a coincidence or what. The outcome of the events was not recovered.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Received vaccine at a different facility (CVS) on 2/10/2021 and presented to this facility ED 02/11/2021 from facility with confusion.  CT negative, UTI present but present prior to visit.  antibiotics for UTI, discharge back to facility.
pt recv vax 24OCT96 & 26OCT96 pt devel a series of 3 to 4 arc-like pruritic lesions @ the inj site;w/in 2 days pt had recovered from exp;pt was vaccinated w/a rabies vax on an unspecified date & had the same rxn;
Mother had signed consent for child to receive flu shot.  Afterward, it was noticed that she had taken him to another pediatrician for a flu shot on 10/14/22.  Child was monitored.  No adverse reactions.
Pink-Red Dots; Swelling; Moderna Vaccine Administered in Thigh; Hardness; This spontaneous case was reported by a consumer and describes the occurrence of INDURATION (Hardness), MACULE (Pink-Red Dots), SWELLING (Swelling) and PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Moderna Vaccine Administered in Thigh) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced INDURATION (Hardness) and PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Moderna Vaccine Administered in Thigh). On 06-Mar-2021, the patient experienced MACULE (Pink-Red Dots) and SWELLING (Swelling). On 15-Feb-2021, INDURATION (Hardness) and PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Moderna Vaccine Administered in Thigh) had resolved. At the time of the report, MACULE (Pink-Red Dots) and SWELLING (Swelling) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information not provided. Treatment included "Cortizone-10" - Self medicating to try to alleviate symptoms "Cold Compress" - Self medicating to try to alleviate the symptoms
Patient experienced painful injection and then felt light headed. Onsite EMS was called vitals HR 77  BP 166/71 patient also explain that she was sick for 5 days after her 1st vaccination. She felt better and went home.
Discharge Summary MD (Physician) ? ? Hospitalist Physician Discharge Summary   Patient ID: MRN:  Name: Patient Age: 70 y.o. Birthday:  Admit Date: 8/14/2022  1:08 PM Discharge Date:  8/17/2022 Unit: 3A116/3A116A Admitting Physician:  Discharge Physician: M.D.   Discharge Diagnosis: Principal Problem:   Idiopathic acute pancreatitis Active Problems:   COVID-19   Essential hypertension   Hypokalemia       HPI: "The patient is a 70 y.o. female, presented on 8/14/2022 with the above. . The symptoms/labs were thought to be marked in severity and unstable. Onset several days ago. Associated symptoms include abdominal pain . Alleviated by none. The patient was diagnosed with COVID 19 on the 8th of this month. She was given steroid and paxlovid as she was not severly symptomatic. 3 days ago she began to have abdominal pain nausea and vomting. She was not able to take her paxlovid due to the vomiting. She comes in today with the above. She was found to have a lipase 100. CT of the abdomen and pelvis showed Acute pancreatitis. She has never had pancreatitis before. She denies frequent alcohol use. She is post cholecystectomy. She has been admitted for further management. "   Hospital Course:  The patient was admitted to the hospital and was evaluated and treated per below.      * Idiopathic acute pancreatitis Description of the Problem/Progression:  Plan:  o Acute pancreatitis. Patient reports feeling much better. However lab showed initially bilirubin and LFTs trending up as well as serum lipase. Continued IV fluid hydration. Patient denies any history of alcohol intake. Lipid profile is unremarkable. Lipase trended down back to normal and T Bili normalized with near normal LFT's. Patient tolerated clearly a diet and was advanced to low-fat. She continued to tolerate her diet. Consulted GI and advised MRCP initially. Patient was unable to tolerate due to Claustrophobia. With her improving GI advised no further plans for endoscopy or imaging. Patient was cleared for discharge to follow up outpatient. o COVID-19 virus infection. Remains on room air. Chest x-ray shows no focal consolidation. Started on IV Remdesivir on admission due to elevated risk. Finished course day 3 / 3. o Hypokalemia. Treated in the emergency room. Continue to monitor lab closely and treat as needed with IV/oral K replacement until normalized. o Hypertension. Controlled. Continue same treatment. Follow up daily labs.        Physical Exam on the Date of Discharge: Stable and improved.      Consults:   IP CONSULT TO SOCIAL WORK IP CONSULT TO GASTROENTEROLOGY   Significant Diagnostic Studies:    labs, radiology, and cardiac graphics: per chart.     Disposition:  home   Discharge Condition:  good
One week after the third dose of the vaccine, I had to have a Cardioversion. I take some medication to lower my blood pressure to take the strain off my heart. My Cardiologist was adjusting my medication and I was monitoring my blood pressure. I took my blood pressure and my heart rate was a little elevated a couple of days before my vaccine. I got a Flu shot at the same time as the COVID-19 vaccine. The evening after I got my shot my heart rate was fluctuating and my blood pressure readings were unusual. I went to the ER and I was diagnosed with Atrial Flutter. I was given a Cardioversion on 10/20/2021, which was a week after the vaccine.
MMR vaccine was expired (4 days) and check expiration date was missed at time that vaccine was given, then on documentation of administration, date was noted as expired.
BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 10/07/2021. PATIENT FULLY VACCINATED ON 04/11/2021. PATIENT RECEIVED MONOCLONAL ANTIBODY ON 10/08/2021.
Felt nauseas and has headache since she received the vaccine; Felt nauseas and has headache since she received the vaccine; A spontaneous report was received from a consumer concerning a 78-year-old female patient who received Moderna's COVID-19 vaccine and experienced the event "felt nauseas and has headache since she received the vaccine".  There were no medical history and concomitant medications reported.  On 29-Dec-2020, the same day as the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  On 29-Dec-2020 the patient developed nausea and a headache.    Action taken with mRNA-1273 in response to the events were not provided.  The outcome of the events "felt nauseas and has headache since she received the vaccine" was unknown.; Reporter's Comments: A spontaneous report concerns a 78-year-old female patient who experienced the non-serious event s of "felt nauseas and has headache since she received the vaccine". The events occurred on the same day after the administration of the first dose of mRNA-1273 (lot number unknown, expiration date unknown). Nausea and headache are consistent with the known safety profile of the mRNA-1273 vaccine and based on the current available information and temporal association between the use of the mRNA-1273 vaccine and onset of the reported events, a causal relationship cannot be excluded.
Within half hour of receiving injection I experienced radiating burning from the injection site across my shoulders and upper back. The sensation continued until I fell asleep at 11:00pm. The following day I experienced pain all over my body. I believe it may be related to fibromyalgia such that what would have been typically reported aches were exacerbated by the fibro nerve pain response. I experienced diminishing pain over a period of 3 days post-injection. The fatigue was also worse than described by vaccinated family & friends. I had a bearable with Tylenol headache for 2 of the 3 days.
This case was reported by a consumer (friend of subject's mother) and described the occurrence of fever in a 2-year-old male subject who was vaccinated with Hepatitis A vaccine (manufacturer unspecified). A physician or other health care professional has not verified this report. On an unspecified date the subject received a dose of Hepatitis A vaccine (unknown details). One day after vaccination with Hepatitis A vaccine, the subject experienced fever. Three days after vaccination with Hepatitis A vaccine, the subject experienced grimacing  and repetitive eye blinking. No additional details were available at the time of reporting. The reporter will encourage the subject's mother to contact GSK directly to provide additional details. At the time of reporting the outcome of the events were unspecified. The reporter also reported another case. See case A1017127A for details on the other case.
neck pain; swelling on injection site; headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (neck pain), VACCINATION SITE SWELLING (swelling on injection site) and HEADACHE (headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NECK PAIN (neck pain), VACCINATION SITE SWELLING (swelling on injection site) and HEADACHE (headache). At the time of the report, NECK PAIN (neck pain), VACCINATION SITE SWELLING (swelling on injection site) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. Treatment information not provided.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 53-year-old male patient received BNT162b2 (BNT162B2), on 04Apr2021 as dose 1, single (Lot number: EW0151), in left arm and on 28Apr2021 as dose 2, single (Lot number: ER8736) at the age of 52 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 02Nov2021 as dose 3 (booster), single (Lot number: 033F21A), in right arm and on 04Apr2022 as dose 4 (booster), single (Lot number: 005M21A), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Obesity" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Aug2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative; Negative. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Patient received Paxlovid on 15Aug2022, lot number: 2815213 and stop date was on 19Aug2022. Reported Event: Paxlovid rebound. Two negative rapid tests and no symptoms followed by return of symptoms.
Fever- 101.2 degrees, flu-like symptoms, fatigue, headache, loss of appetite, chills, very sore arm I'm now about 24 hours post vaccination.
Pt showed me a picture on her phone of her arm which shows a  large baseball size area of redness and swelling in the lower deltoid area with the redness going down the arm to the elbow and a little bit into the forearm. It hurt. She got it after she had the last Moderna COVID Bivalent vaccine. She said it lasted for about a week. Each time she gets the vaccine the area involved gets bigger. She has had only the Moderna vaccines. She's afraid to get any more of them.  I didn't see it as she came in weeks after her reaction. She did have the Fluzone given in the same arm but said it was given higher up in the arm.
Patient received FLUVIRIN PF on 10/24/17. At time of shot and following two days patient had stinging in area of vaccine. After 2 days, patient had swelling and pain in that area. As of 11/14/17, patient will has some pain and swelling. Advised patient to receive medical attention. (Patient noted no redness around site).
felt a little not like themselves; arm hurt a little bit; achy joints; Headache; red rash underneath my breast all way down to my navel/rash below their breast to navel in the front of their torso; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt a little not like themselves), RASH (red rash underneath my breast all way down to my navel/rash below their breast to navel in the front of their torso), VACCINATION SITE PAIN (arm hurt a little bit), ARTHRALGIA (achy joints) and HEADACHE (Headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939905) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL]) for an unknown indication.    On 06-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Nov-2021, the patient experienced RASH (red rash underneath my breast all way down to my navel/rash below their breast to navel in the front of their torso). On an unknown date, the patient experienced FEELING ABNORMAL (felt a little not like themselves), VACCINATION SITE PAIN (arm hurt a little bit), ARTHRALGIA (achy joints) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at a dose of as necessary. At the time of the report, FEELING ABNORMAL (felt a little not like themselves) had resolved, RASH (red rash underneath my breast all way down to my navel/rash below their breast to navel in the front of their torso) was resolving and VACCINATION SITE PAIN (arm hurt a little bit), ARTHRALGIA (achy joints) and HEADACHE (Headache) outcome was unknown.            No Treatment information was reported   This case was linked to MOD-2021-380153, MOD-2021-380167 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-Nov-2021: Reporter contact details and Patient Demographics updated, Concomitant added, Events (Vaccination site reaction) (Headache) (Arthralgia) (Feelng Abnormal) added.
Pt developed fever in less than 24 hours of vaccination. Pt experienced a seizure (focal / generalized) 26 hours post vax.
Concerns with reaction to vaccine. Aunt called, patient received vaccines today and Aunt stated she was crying in pain from vaccines and saying her lower abdomen hurt and fingers on both hands felt numb. The left arm where she received the flu vaccine and MenB vaccine was hurting the worst and patient was complaining that she was having the chills and could not stop shaking. Aunt gave child ibuprofen around 4:00pm, asked Aunt how much Ibuprofen was given - she stated child took two prescription 800mg. Talked with doctor about vaccine concerns and reaction, also discussed amount of ibuprofen patient. Doctor recommended that I tell Aunt to call poison control, which she did, and she called us back to let us know that poison control said the abdominal pain could come from the amount of ibuprofen she took but the other symptoms needed to be mentioned to a physician. Advised Aunt to place cold compress on tender arm and offer clear liquids. I told her I would follow up with them prior to leaving clinic this evening. Time of Call: 02/13/2017 05:13 PM. Aunt called back around 5:20pm, the patient started with a fever of 104 and was shaking on and off. Aunt stated patient was shaking so bad she was rubbing the skin on the inside of her feet raw. I advised Aunt to take patient to one of the hospitals if she felt calm enough to drive her, if not - ok to take her to different hospital or call ambulance for transportation to E/D. Aunt was ok to take her to hospital, which ever one she could get to first. If patient started with seizure like activity, vomiting, syncope, or chest pain prior to leaving for the hospital, call ambulance. Aunt agreed with plan. Response from Doctor: Acknowledged. We need to fill out a VAERS report. Please follow up with patient tomorrow.
This case was reported by a consumer via call center representative and described the occurrence of pain in a 69-year-old male patient who received SHINGRIX for prophylaxis. Concomitant products included losartan. On 26th July 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 26th July 2018, less than a day after receiving SHINGRIX, the patient experienced pain, headache, sweating and erythema. On an unknown date, the outcome of the pain, headache, sweating and erythema were recovered/resolved. It was unknown if the reporter considered the pain, headache, sweating and erythema to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the patient's wife. The patient received SHINGRIX on right arm. This case has been linked to the US2018139533 and US2018139538, reported by the same reporter.